(Q35090469)

6 August 2017

1 reference

title

Cardiovascular pharmacogenomics: current status, future prospects (English)

1 reference

6 August 2017

1 reference

Jeffrey L Anderson

1 reference

6 August 2017

John F Carlquist

series ordinal

1 reference

6 August 2017

Benjamin D Horne

series ordinal

1 reference

6 August 2017

Joseph B Muhlestein

series ordinal

1 reference

6 August 2017

publication date

1 March 2003

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

6 August 2017

published in

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

71-83

1 reference

Drug target pharmacogenomics: an overview

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Pharmacogenetics and the practice of medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

The Sequence of the Human Genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

A physical map of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Implications of the human genome for understanding human biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Pharmacogenetics and drug-induced arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

A common polymorphism associated with antibiotic-induced cardiac arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

The ACE gene polymorphism and cough threshold for capsaicin after cilazapril usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Preprescription genotyping: not yet ready for prime time, but getting there.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Beta-adrenergic receptors in the failing heart: the good, the bad, and the unknown

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

-455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fibrinogen. REGRESS group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Searching for genetic determinants in the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Replication validity of genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Testing for population subdivision and association in four case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

The structure of haplotype blocks in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

A first-generation linkage disequilibrium map of human chromosome 22

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

Apolipoprotein E Alleles and Risk of Coronary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840300800I110

10.1177/107424840300800I110

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference